Pretreatment With Intracoronary Enalaprilat Protects Human Myocardium During Percutaneous Coronary Angioplasty

Journal of the American College of Cardiology

Volumn 49, Issue 15, 2007, Pages 1607-1610

  Leesar, Massoud A ^a   Jneid, Hani ^a   Tang, Xian Liang ^a   Bolli, Roberto ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; NITRIC ACID DERIVATIVE;

ADULT; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DEMOGRAPHY; DRUG MECHANISM; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; MALE; PAIN ASSESSMENT; PRIORITY JOURNAL; ST SEGMENT; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; ENALAPRILAT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRALESIONAL; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MIDDLE AGED; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 34047246485     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.01.060     Document Type: Article

References (14)

1. ACE Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. Circulation 97 (1998) 2202-2212
2. Pfeffer M.A., McMurray J.J., Velazquez E.J., et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349 (2003) 1893-1906
3. Linz W., Wiemer G., and Scholkens B.A. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies. Diabetes 45 Suppl 1 (1996) S51-S58
4. Leesar M.A., Stoddard M.F., Manchikalapudi S., and Bolli R. Bradykinin-induced preconditioning in patients undergoing coronary angioplasty. J Am Coll Cardiol 34 (1999) 639-650
5. Martorana P.A., Kettenbach B., Breipohl G., Linz W., and Scholkens B.A. Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. Eur J Pharmacol 182 (1990) 395-396
6. Morris S.D., and Yellon D.M. Angiotensin-converting enzyme inhibitors potentiate preconditioning through bradykinin B2 receptor activation in human heart. J Am Coll Cardiol 29 (1997) 1599-1606
7. ATP channel opener on warm up angina. Eur Heart J 26 (2005) 598-606
8. Heusch G. Nitroglycerin and delayed preconditioning in humans: yet another new mechanism for an old drug. Circulation 103 (2001) 2876-2878
9. Birincioglu M., Yang X.M., Critz S.D., Cohen M.V., and Downey J.M. S-T segment voltage during sequential coronary occlusions is an unreliable marker of preconditioning. Am J Physiol 277 (1999) H2435-H2441
10. Leesar M.A., Stoddard M.F., Xuan Y.T., Tang X.L., and Bolli R. Nonelectrocardiographic evidence that both ischemic preconditioning and adenosine preconditioning exist in humans. J Am Coll Cardiol 42 (2003) 437-445
11. Ertl G., Kloner R.A., Alexander R.W., and Braunwald E. Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor. Circulation 65 (1982) 40-48
12. Hock C.E., Ribeiro L.G., and Lefer A.M. Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarction. Am Heart J 109 (1985) 222-228
13. Schulz R., Post H., Vahlhaus C., and Heusch G. Ischemic preconditioning in pigs: a graded phenomenon: its relation to adenosine and bradykinin. Circulation 98 (1998) 1022-1029
14. Haber H.L., Powers E.R., Gimple L.W., et al. Intracoronary angiotensin-converting enzyme inhibition improves diastolic function in patients with hypertensive left ventricular hypertrophy. Circulation 89 (1994) 2616-2625